CAR-T-19 Injection

CD19-directed CAR-T cell therapy · Beijing Yongtai Ruike Biotechnology Company Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T-19 Injection, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL [Phase 2]